APA (7th ed.) Citation

Soga, N., Okuda, M., Hanamura, M., Sugimura, Y., & Iwamoto, T. (2010). Risk Factors Contributing to the Development of Hypocalcemia after Zoledronic Acid Administration in Patients with Bone Metastases of Solid Tumor. Biological & pharmaceutical bulletin, 33(4), 721-724. https://doi.org/10.1248/bpb.33.721

Chicago Style (17th ed.) Citation

Soga, Norihito, Masahiro Okuda, Miho Hanamura, Yoshiki Sugimura, and Takuya Iwamoto. "Risk Factors Contributing to the Development of Hypocalcemia After Zoledronic Acid Administration in Patients with Bone Metastases of Solid Tumor." Biological & Pharmaceutical Bulletin 33, no. 4 (2010): 721-724. https://doi.org/10.1248/bpb.33.721.

MLA (9th ed.) Citation

Soga, Norihito, et al. "Risk Factors Contributing to the Development of Hypocalcemia After Zoledronic Acid Administration in Patients with Bone Metastases of Solid Tumor." Biological & Pharmaceutical Bulletin, vol. 33, no. 4, 2010, pp. 721-724, https://doi.org/10.1248/bpb.33.721.